Eurofarma and the British consultancy group, IN-PART, recently announced a partnership for projects in the field of antibacterial therapies within the academic environment.

Academic research groups are asked to share their initiatives on programs looking at potential new antibiotics, an initiative that reinforces Eurofarma's innovative DNA to expand its performance in the advancement of innovative molecules and medicines.

After the end of the application period, which runs until June 13, IN-PART will analyze all the projects with the greatest potential to then start a more in-depth development with Eurofarma.

To apply, applicants must include a 200-300 word abstract about the project, detailing its most relevant aspects. Publicly available information, such as articles, conference slides, or academic profiles, are also accepted for application.

Click here to learn more and apply for the opportunity.